Organization
Laboratory of Oncology in South China
5 abstracts
Abstract
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.Org: Sun Yat Sen University Cancer Center, Laboratory of Oncology in South China, Geneplus-Beijing Institute, Geneplus-Beijing Insititute, Department of Colorectal Surgery,
Abstract
A phase II clinical evaluation of radiofrequency ablation (RFA) combined with regorafenib and toripalimab in patients with colorectal cancer with liver metastases.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center Gansu Hospital, Guangzhou, China,
Abstract
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.Org: Sun Yat-sen University Cancer Center Gansu Hospital, Sun Yat Sen University Cancer Center, Laboratory of Oncology in South China,
Abstract
Peripheral pre-existing cancer-antigen specific T-cell immunity as predictive biomarker for immunotherapy in NSCLC patients.Org: Laboratory of Oncology in South China, School of Health Sciences, University of Skövde, University of Thessaly, Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital,
Abstract
Combinatorial analysis of CD4+Tregs and CD8+Teff to predict response to ICI in patients with ES-SCLC.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, University Hospital of Larissa, Laboratory of Oncology in South China, School of Health Sciences, University of Skövde, University of Thessaly,